Active Ingredient History

  • Now
Abciximab, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.   Wikipedia

More Chemistry
7e3 | 7e3 antibody | abciximab | abxicimab | antigpiibiiia | c7e3 | c7e3 fab | centorx | chimeric 7e3 fab | clotinab | reopro


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue